Immunopathogenesis of dengue hemorrhagic fever and shock syndrome: Role of TAP and HPA gene polymorphism

Human Immunology

Volumn 68, Issue 12, 2007, Pages 973-979

  Soundravally, R ^a   Hoti, S L ^a  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

Author keywords

Human platelet antigen; Severe dengue infection; TAP

Indexed keywords

CARRIER PROTEIN; HLA ANTIGEN CLASS 2; PROTEIN HPA1; PROTEIN HPA2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIGENS, HUMAN PLATELET; ATP-BINDING CASSETTE TRANSPORTERS; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 37849040687     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.09.007     Document Type: Article

References (34)

1. Gubler D.J. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11 (1998) 480
2. Bhakdi S., and Kazatchkine M.D. Pathogenesis of dengue: an alternative hypothesis. Southeast Asian J Trop Med Public Health 21 (1990) 652
3. Halstead S.B. Dengue. Curr Opin Infect Dis 15 (2002) 471
4. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179 (1999) 755
5. Lei H.Y., Yeh T.M., Liu H.S., Lin Y.S., Chen S.H., and Liu C.C. Immunopathogenesis of dengue virus infection. J Biomed Sci 8 (2001) 377
6. Halstead S.B., Venkateshan C.N., Gentry M.K., and Larsen L.K. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol 132 (1984) 1529
7. Littaua R., Kurane I., and Ennis F.A. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144 (1990) 3183
8. Sierra Bde L., Kouri G., and Guzman M.G. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152 (2007) 533
9. Stephens H.A., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60 (2002) 309
10. Chaturvedi U., Nagar R., and Shrivastava R. Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 47 (2006) 155
11. LaFleur C., Granados J., Vargas-Alarcon G., Ruiz-Morales J., Villarreal-Garza C., Higuera L., et al. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol 63 (2002) 1039
12. Chiewsilp P., Scott R.M., and Bhamarapravati N. Histocompatibility antigens and dengue hemorrhagic fever. Am J Trop Med Hyg 30 (1981) 1100
13. Loke H., Bethell D., Phuong C.X., Day N., White N., Farrar J., et al. Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 67 (2002) 102
14. Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A., Lowhnoo T., Kajaste-Rudnitski, et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37 (2005) 507
15. Momburg F., Mullbacher A., and Lobigs M. Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J Virol 75 (2001) 5663
16. Cao B., Tian X., Li Y., Jiang P., Ning T., Xing H., et al. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 26 (2005) 1280
17. Kuzushita N., Hayashi N., Kanto T., Takehara T., Tatsumi T., Katayama K., et al. Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection. Gastroenterology 116 (1999) 1149
18. Middleton D., Megaw G., Cullen C., and Hawkins S. TAP1 and TAP2 polymorphism in multiple sclerosis patients. Hum Immunol 40 (1994) 131
19. Boonpucknavig S., Vuttiviroj O., Bunnag C., Bhamarapravati N., and Nimmanitya S. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am J Trop Med Hyg 28 (1979) 881
20. Wang S., He R., Patarapotikul J., Innis B.L., and Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 213 (1995) 254
21. Hoti S.L., Soundravally R., Rajendran G., Das L.K., Ravi R., and Das P.K. Dengue and dengue haemorrhagic fever outbreaks in Pondicherry, South India, during 2003-2004: emergence of DENV-3. Dengue Bulletin 30 (2006) 42
22. World Health Organization. Dengue Haemorrhagic fever. diagnosis, treatment, prevention, and control. (2nd ed.) (1997), World Health Organization, Geneva
23. Harris E., Roberts T.G., Smith L., Selle J., Kramer L.D., Valle S., et al. Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase-PCR. J Clin Microbiol 36 (1998) 2634
24. Powis S.H., Tonks S., Mockridge I., Kelly A.P., Bodmer J.G., and Trowsdale J. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 37 (1993) 373
25. Skogen B., Bellissimo D.B., Hessner M.J., Santoso S., Aster R.H., Newman P.J., et al. Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion 34 (1994) 955
26. Kelly A., Powis S.H., Kerr L.A., Mockridge I., Elliot T., Bastin J., et al. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatiility complex. Nature 355 (1992) 641
27. Safa A.R., Stern Choi K., Agresti M., Tamai I., Mehta N.D., and Robinson I.B. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185-Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA 87 (1990) 7225
28. Obst R., Armandola E.A., Nijenhuis M., Momburg F., and Hammerling G.J. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur J Immunol 25 (1995) 2170
29. Mandelbaum M., Koren D., Eichelberger B., Auerbach L., and Panzer S. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization. Vox Sang 89 (2005) 39
30. Braud V., Chevrier D., Bignon J.D., Kaplan C., Cesbron A., Valentin N., et al. Susceptibility to alloimmunisation to platelet HPA1a antigen involves TAP1 polymorphism. Hum Immunol 41 (1994) 141
31. Semana G., Zazoun T., Alizadeh M., Morel-Kopp M.C., Genetet B., and Kaplan C. Genetic susceptibility and anti-human platelet antigen 5b alloimmunization role of HLA class II and TAP genes. Hum Immunol 46 (1996) 114
32. Ulrichts H., Vanhoorelbeke K., Cauwenberghs S., Vauterin S., Kroll H., et al. von Willebrand factor but not α-thrombin binding to platelet glycoprotein ibα is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol 23 (2003) 1302
33. Gonzalez-Conejero R., Lozano M.L., Rivera J., Corral J., Iniesta J.A., Moraleda J.M., et al. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 92 (1998) 2771
34. Thude H., Gatzka E., Anders O., and Barz D. Allele frequencies of human platelet antigen 1, 2, 3, and 5 systems in patients with chronic refractory autoimmune thrombocytopenia and in normal persons. Vox Sang 77 (1999) 149